Ishiwada Naruhiko, Shinjoh Masayoshi, Kusama Yoshiki, Arakawa Hirokazu, Ohishi Tomohiro, Saitoh Akihiko, Suzuki Akira, Tsutsumi Hiroyuki, Nishi Junichiro, Hoshino Tadashi, Mitsuda Toshihiro, Miyairi Isao, Iwamoto-Kinoshita Noriko, Kobayashi Hisato, Satoh Kouichiro, Shimizu Akihiko, Takeshita Kenichi, Tanaka Takaaki, Tamura Daisuke, Tokunaga Osamu, Tomita Kentaro, Nagasawa Koo, Funaki Takanori, Furuichi Muhehiro, Miyata Ippei, Yaginuma Mizuki, Yamaguchi Yoshio, Yamamoto Shota, Uehara Suzuko, Kurosaki Tomomichi, Okada Kenji, Ouchi Kazunobu
From the Editor of the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.
Committee member for English journals for the Japanese Society for Pediatric Infectious Diseases, Tokyo, Japan.
Pediatr Infect Dis J. 2023 Oct 1;42(10):e369-e376. doi: 10.1097/INF.0000000000004041. Epub 2023 Aug 8.
The members of the Japanese Society for Pediatric Infectious Diseases and the Japanese Society of Pediatric Pulmonology have developed Guidelines for the Management of Respiratory Infectious Diseases in Children with the objective of facilitating appropriate diagnosis, treatment and prevention of respiratory infections in children. The first edition was published in 2004 and the fifth edition was published in 2022. The Guideline 2022 consists of 2 parts, clinical questions and commentary, and includes general respiratory infections and specific infections in children with underlying diseases and severe infections. This executive summary outlines the clinical questions in the Guidelines 2022, with reference to the Japanese Medical Information Distribution Service Manual. All recommendations are supported by a systematic search for relevant evidence and are followed by the strength of the recommendation and the quality of the evidence statements.
日本小儿传染病学会和日本小儿肺科学会的成员制定了《儿童呼吸道传染病管理指南》,目的是促进对儿童呼吸道感染进行适当的诊断、治疗和预防。第一版于2004年出版,第五版于2022年出版。《2022年指南》由临床问题和评论两部分组成,涵盖了一般呼吸道感染以及患有基础疾病儿童的特定感染和严重感染。本执行摘要参照日本医学信息传播服务手册概述了《2022年指南》中的临床问题。所有建议均通过对相关证据的系统检索得到支持,并附有建议的强度和证据陈述的质量说明。